OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)
Sho Furusawa, Hiroshi Nomoto, Chiho Oba‐Yamamoto, et al.
Endocrine Journal (2024) Vol. 71, Iss. 6, pp. 603-616
Open Access | Times Cited: 7
Sho Furusawa, Hiroshi Nomoto, Chiho Oba‐Yamamoto, et al.
Endocrine Journal (2024) Vol. 71, Iss. 6, pp. 603-616
Open Access | Times Cited: 7
Showing 7 citing articles:
The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study
Hiroya Kitsunai, Yuichi Shinozaki, Sho Furusawa, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 129-129
Open Access
Hiroya Kitsunai, Yuichi Shinozaki, Sho Furusawa, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 129-129
Open Access
GLP-1 receptor agonist-based and cardiovascular risk: a review of mechanisms
Neerav Mullur, Arianne Morissette, Nadya M. Morrow, et al.
Journal of Endocrinology (2024) Vol. 263, Iss. 1
Open Access | Times Cited: 2
Neerav Mullur, Arianne Morissette, Nadya M. Morrow, et al.
Journal of Endocrinology (2024) Vol. 263, Iss. 1
Open Access | Times Cited: 2
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies
Arianne Morissette, Erin E. Mulvihill
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 1
Arianne Morissette, Erin E. Mulvihill
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 1
Semaglutide use in people with obesity and type 2 diabetes from real‐world utilization data: An analysis of the All of US Program
Craig S. Mayer, Paul Fontelo
Diabetes Obesity and Metabolism (2024)
Open Access | Times Cited: 1
Craig S. Mayer, Paul Fontelo
Diabetes Obesity and Metabolism (2024)
Open Access | Times Cited: 1
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches
Arianne Morissette, Erin E. Mulvihill
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access
Arianne Morissette, Erin E. Mulvihill
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access
Real-world Evidence on Oral Semaglutide for the Management of Type 2 Diabetes. A Narrative Review for Clinical Practice
Massimo Marassi, Gian Paolo Fadini
Clinical Therapeutics (2024)
Open Access
Massimo Marassi, Gian Paolo Fadini
Clinical Therapeutics (2024)
Open Access
Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes
Junko Oya, Mika Shimizu, Ryo Kubota, et al.
Journal of Diabetes Investigation (2024)
Open Access
Junko Oya, Mika Shimizu, Ryo Kubota, et al.
Journal of Diabetes Investigation (2024)
Open Access
